Horizon Therapeutics
HZNP
#749
Rank
S$35.83 B
Marketcap
$156.50
Share price
0.00%
Change (1 day)
5.34%
Change (1 year)

Horizon Therapeutics (HZNP) - Cash on Hand

Cash on Hand as of June 2023 : S$3.31 Billion

According to Horizon Therapeutics 's latest financial reports the company has S$3.31 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Horizon Therapeutics - Cash on Hand chart (from 2009 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$3.15 B47.64%
2021-12-31S$2.13 B-22.36%
2020-12-31S$2.75 B89.63%
2019-12-31S$1.45 B10.79%
2018-12-31S$1.30 B30.33%
2017-12-31S$1.00 B36.4%
2016-12-31S$0.73 B-39.41%
2015-12-31S$1.21 B320.57%
2014-12-31S$0.28 B183.54%
2013-12-31S$0.10 B-19.89%
2012-12-31S$0.12 B447.08%
2011-12-31S$23.26 M235.49%
2010-12-31S$6.93 M-31.01%
2009-12-31S$10.05 M-50.03%
2008-12-31S$20.11 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$12.12 B 265.61%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.52 B 187.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$13.39 B 303.79%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.01 B-69.43%๐Ÿ‡ฎ๐Ÿ‡ณ India
S$19.63 B 492.10%๐Ÿ‡บ๐Ÿ‡ธ USA